Product Details
| Product Name: Tirzepatide | CAS No.: 2023788-19-2 |
| EC-No.: 200-001-8 | Min. Order: 1kg |
| Purity: 100.4% | Supply Ability: 1000kg |
| Release date: 2026/07/01 |
Items | Specifications | Results |
Appearance | White or off-white powder;Freely soluble in water. | Conforms |
Specific Rotation | Calculates on the anhydrous and sodium-ion-free basis,the specific rotation should be -23.5°to -33.5° | -29.7° |
Identification | 1)The retention time of the main peak of the test solution shall correspond to that of the main peak of the reference solution. | Conforms |
2)Amino Acid Ratio:Asp1.6~2.4、Glu3.2~4.8、Thr 1.6~2.4、Ala3.2~4.8、(Aib)1.6~2.4、Tyr1.6~2.4、Val 0.8~1.2 | Conforms | |
3)MS:Relative Molecular Mass4813.5±1.0Da | Conforms | |
pH | 6.0~9.0 | 6.8 |
Clarity and Color of Solution | The solution shall be clear and colorless. | Conforms |
Water Content | ≤7.0% | 1.3% |
Acetic Acid | ≤0.5% | 0.04% |
Trifluoroacetic Acid | ≤0.5% | 0.01% |
Sodium Ion | ≤5.0% | 1.2% |
Residual Solvents | Methanol≤0.3% Dichloromethane≤0.06% Acetonitrile≤0.041% N,N-DMF≤0.088% | 0.002% ND 0.008% ND |
High Molecular Weight Substances | Single impurity≤0.3% Total impurities≤0.8% | 0.04% 0.04% |
Related Substances | Impurity 1≤0.5% Impurity 2≤0.5% Impurity 3≤0.5% Impurity 4≤0.5% Impurity 5≤0.5% Impurity 6≤0.5% Other single impurity≤0.5% Total impurities≤2.0% | ND ND 0.10% 0.26% 0.10% 0.09% ≤0.24% 0.79% |
Purity | ≥98.0% | 99.2% |
Bacterial Endotoxin | The endotoxin in each 1mg of Tirzepatide shall be less than 5EU. | Conforms |
Microbial limits | Total Yeasts and Molds Count(TYMC)≤100cfu/g | 6.0cfu/g |
Total Yeasts and Molds Count(TYMC)≤100cfu/g | <1cfu/g | |
Assay | It contains 95.0% to 105.0% of Tirzepatide,calculated on the anhydrous and sodium-ion-free basis. | 100.4% |
Assay of Peptide | ≥80.0% | 96.7% |
Conclusion | The product conforms to the above specifications. | |
Tirzepatide is a synthetic linear peptide comprised of 39 amino acids, chemically modified with a C20 fatty diacid side chain to prolong its action. It is a dual glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptor agonist.
Pharmaceutical vs. Chemical Grade
Pharmaceutical Grade: Marketed as Mounjaro? (for type 2 diabetes) and Zepbound? (for weight management). Formulated for injection.
Chemical/Research Grade: A high-purity (>95%, often >98%), lyophilized (freeze-dried) powder, typically sold in milligram quantities. It is not sterile or formulated for human use.
Primary Uses in Chemical and Research Grades
In this context, it serves as a precise biochemical tool:
Pharmacology & Biochemistry Research:
Mechanism of Action Studies: Used in vitro (cell cultures) and in vivo (animal models) to dissect the signaling pathways, receptor binding kinetics, and downstream effects of dual GIP/GLP-1 agonism.
Comparative Studies: To benchmark efficacy and selectivity against other incretin mimetics (e.g., semaglutide) in controlled experimental systems.
Analytical Reference Standard:
Quality Control: Serves as the primary reference standard in HPLC, LC-MS/MS, and other assays to identify, quantify, and determine the purity of tirzepatide in pharmaceutical development.
Bioanalysis: Used to develop and validate methods for measuring tirzepatide concentrations in biological matrices (plasma, tissues) during preclinical pharmacokinetic studies.
Preclinical Drug Development:
Proof-of-Concept Studies: Employed in animal models of obesity, diabetes, and metabolic syndrome to investigate therapeutic potential, optimal dosing, and safety profiles before clinical trials.
Metabolic Research: A key tool for studying integrated metabolism, energy homeostasis, and appetite regulation in specialized research settings.
Key Distinction for Handling
Not for Human Use: For laboratory research only.
Handling: Requires reconstitution with appropriate buffers. It is a peptide, requiring storage at -20°C or below to maintain stability.
Regulatory: While a research chemical, it is often subject to controlled purchase due to its status as a patented pharmaceutical agent.
Summary
| Aspect | Description |
|---|---|
| Identity | Synthetic 39-amino acid peptide, dual GIP/GLP-1 receptor agonist. |
| Chemical Grade | High-purity, lyophilized powder for non-therapeutic research. |
| Primary Research Uses | 1. Mechanistic Tool: For studying dual incretin receptor pharmacology. 2. Analytical Standard: For quantification and method validation. 3. Preclinical Agent: For metabolic disease modeling in animals. |
In essence, chemical-grade tirzepatide is a critical reference molecule and investigational tool for scientists studying metabolic diseases, developing analytical methods, and advancing understanding of incretin biology.



Company Profile Introduction
You may like
-
CAS:
-
CAS:1260-17-9
-
CAS:642443-86-5
Recommended supplier
| Product name | Price | Suppliers | Update time | |
|---|---|---|---|---|
| $20.00 |
VIP1Y
|
Rongchuang International
|
2026-07-01 | |
| $8.00 |
VIP1Y
|
Yiwu Jingpinhui Plastic Co., Ltd.
|
2026-07-01 | |
| $15.00 |
VIP6Y
|
Shanghai UCHEM Inc.
|
2026-07-01 | |
| $1.00 |
VIP6Y
|
RongNa Biotechnology Co.,Ltd
|
2026-07-01 | |
| $60.00 |
VIP1Y
|
Guangzhou Pros Bio Technology Co., Ltd.
|
2026-07-01 | |
| $5.00 |
VIP2Y
|
Hebei Jiafan Trading Company Limited
|
2026-07-01 | |
| $9.00 |
VIP1Y
|
Guangzhou XinPeptide International Co.,Ltd
|
2026-07-01 | |
|
VIP2Y
|
Shandong Huizhihan Supply Chain Co., Ltd
|
2026-07-01 | ||
|
VIP6Y
|
Sinoway Industrial co., ltd.
|
2026-07-01 | ||
| $150.00 |
VIP1Y
|
Deepharma Inc
|
2026-07-01 |
- Since: 2006-04-03
- Address: Room 2015, No.2 Building Kaixin Mansion, No.107 Jinqiao Ave, Wuhan, China
info@fortunachem.com

China